Foghorn Therapeutics
Price & Volume
Stats
See more52W Range | $3.27-$6.95 |
Market Cap | $370.5M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $36.7M |
Revenue Growth (YoY) | 112.7% |
Gross Profit (12 Mos) | -$42M |
Diluted EPS | -$1.02 |
News
See moreYahoo Finance • last month
Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director
Yahoo Finance • 2 months ago
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
Yahoo Finance • 2 months ago
Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026
Yahoo Finance • 5 months ago
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
About
CEO | Mr. Adrian H. B. Gottschalk |
Address | 99 Coolidge Avenue, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 106 |